Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-29 3:47 pm Unchanged | 2024-03-28 | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors, Inc. | 464,677 9.900% | 0 (Unchanged) | Filing History |
| 2024-05-29 3:43 pm Purchase | 2024-03-28 | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors, Inc. | 464,677 9.900% | 464,677 (New Position) | Filing History |
| 2024-02-14 4:55 pm Purchase | 2023-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 260,731 9.990% | 251,619 (+2761.40%) | Filing History |
| 2024-02-13 8:08 pm Purchase | 2023-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 93,889 9.900% | 55,499 (+144.57%) | Filing History |
| 2024-02-09 4:16 pm Purchase | 2024-01-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Stonepine Capital Management, LLC | 267,673 9.990% | 267,673 (New Position) | Filing History |
| 2024-02-07 09:22 am Purchase | 2024-02-01 | 13G | KIORA PHARMACEUTICALS INC KPRX | Orin Hirschman | 255,556 9.900% | 255,556 (New Position) | Filing History |
| 2024-02-06 10:27 am Sale | 2023-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Mitchell P. Kopin | 13,012 1.500% | -6,185 (-32.22%) | Filing History |
| 2023-06-13 4:02 pm Purchase | 2023-06-06 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 38,390 9.900% | 21,382 (+125.72%) | Filing History |
| 2023-02-14 1:01 pm Purchase | 2022-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Armistice Capital, LLC | 10,000 4.770% | 4,080 (+68.92%) | Filing History |
| 2023-02-13 4:38 pm Purchase | 2022-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 17,008 7.900% | 6,823 (+66.99%) | Filing History |
| 2023-02-13 4:37 pm Sale | 2022-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Macro Fund LP | 0 0.000% | -144,770 (Position Closed) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Mitchell P. Kopin | 19,197 9.000% | 9,564 (+99.28%) | Filing History |
| 2022-08-05 5:23 pm Purchase | 2022-07-26 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 10,185 9.900% | 8,979 (+744.53%) | Filing History |
| 2022-08-01 06:06 am Purchase | 2022-07-26 | 13G | KIORA PHARMACEUTICALS INC KPRX | Mitchell P. Kopin | 9,633 9.990% | 8,353 (+652.58%) | Filing History |
| 2022-07-28 5:09 pm Purchase | 2022-07-26 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 9,112 9.990% | 9,112 (New Position) | Filing History |
| 2022-02-14 6:19 pm Sale | 2021-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Armistice Capital, LLC | 5,920 14.400% | -2,180 (-26.91%) | Filing History |
| 2022-02-11 5:07 pm Sale | 2021-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 1,206 3.300% | -2,413 (-66.68%) | Filing History |
| 2022-01-27 4:48 pm Sale | 2021-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | BIGGER CAPITAL FUND L P | 1,206 3.300% | -1,008 (-45.53%) | Filing History |
| 2022-01-24 10:33 am Sale | 2021-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Empery Asset Management LP | 1,484 4.050% | -929 (-38.50%) | Filing History |
| 2021-08-20 4:45 pm Purchase | 2021-08-11 | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Lind Global Fund II LP | 1,302,933 9.900% | 1,302,933 (New Position) | Filing History |